140 related articles for article (PubMed ID: 3053190)
1. Immunocytochemical detection of neuroblastoma cells infiltrating clinical bone marrow samples.
Beck D; Maritaz O; Gross N; Favrot M; Vultier N; Bailly C; Villa I; Gentilhomme O; Philip T
Eur J Pediatr; 1988 Aug; 147(6):609-12. PubMed ID: 3053190
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical examination of bone marrow in disseminated neuroblastoma.
Carey PJ; Thomas L; Buckle G; Reid MM
J Clin Pathol; 1990 Jan; 43(1):9-12. PubMed ID: 1690223
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow examination in neuroblastoma patients: a morphologic, immunocytochemical, and immunohistochemical study.
Oppedal BR; Storm-Mathisen I; Kemshead JT; Brandtzaeg P
Hum Pathol; 1989 Aug; 20(8):800-5. PubMed ID: 2744752
[TBL] [Abstract][Full Text] [Related]
4. Detection of minimal disease in bone marrow of neuroblastoma patients by immunofluorescence.
Berthold F; Schneider A; Schumacher R; Bosslet K
Pediatr Hematol Oncol; 1989; 6(2):73-83. PubMed ID: 2702075
[TBL] [Abstract][Full Text] [Related]
5. [The significance of immunological analysis for the detection of residual neuroblasts in bone marrow].
Maritaz O; Combaret V; Favrot MC
Pathol Biol (Paris); 1988 Jan; 36(1):21-4. PubMed ID: 3283668
[TBL] [Abstract][Full Text] [Related]
6. [Cytologic detection of neuroblasts in the bone marrow].
Bayle C
Bull Cancer; 1988; 75(1):75-7. PubMed ID: 3282576
[TBL] [Abstract][Full Text] [Related]
7. [Detection of residual cells contaminating the bone marrow in neuroblastoma. Apropos of 80 bone marrow evaluations].
Frappaz D; Maritaz O; Favrot MC; Philip I; Bernard JL; Bailly C; Gentilhomme O; Gentet JC; Zucker JM; Bouffet E
Arch Fr Pediatr; 1987 Nov; 44(9):771-8. PubMed ID: 3446068
[TBL] [Abstract][Full Text] [Related]
8. Detection of residual neuroblastoma cells in bone marrow: comparison of flow cytometry with immunocytochemistry.
Swerts K; De Moerloose B; Dhooge C; Brichard B; Benoit Y; Laureys G; Philippé J
Cytometry B Clin Cytom; 2004 Sep; 61(1):9-19. PubMed ID: 15351977
[TBL] [Abstract][Full Text] [Related]
9. [Significance of application of immunocytochemical detection of GD2 antigen in bone marrow in neuroblastoma patients].
Bolek-Marzec K; Balwierz W; Wieczorek A; Szewczyk K
Przegl Lek; 2010; 67(6):409-12. PubMed ID: 21344771
[TBL] [Abstract][Full Text] [Related]
10. Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantation.
Combaret V; Favrot MC; Kremens B; Philip I; Bailly C; Fontaniere B; Gentilhomme O; Chauvin F; Zucker JM; Bernard JL
Br J Cancer; 1989 Jun; 59(6):844-7. PubMed ID: 2660896
[TBL] [Abstract][Full Text] [Related]
11. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
[TBL] [Abstract][Full Text] [Related]
12. In vivo purging of bone marrow in children with poor-risk neuroblastoma for marrow collection and autologous bone marrow transplantation.
Saarinen UM; Wikström S; Mäkipernaa A; Lanning M; Perkkiö M; Hovi L; Rapola J; Sariola H
J Clin Oncol; 1996 Oct; 14(10):2791-802. PubMed ID: 8874341
[TBL] [Abstract][Full Text] [Related]
13. Limitations of the immunocytochemical detection of isolated tumor cells in frozen samples of bone marrow obtained from melanoma patients.
Schadendorf D; Dorn-Beineke A; Borelli S; Riethmuller G; Pantel K
Exp Dermatol; 2003 Apr; 12(2):165-71. PubMed ID: 12702145
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical detection of bone marrow-invasive neuroblastoma cells.
Nagai J; Kigasawa H; Tomioka K; Koga N; Nishihira H; Nagao T
Eur J Haematol; 1994 Aug; 53(2):74-7. PubMed ID: 7522190
[TBL] [Abstract][Full Text] [Related]
15. Detection of isolated tumor cells in neuroblastoma by immunohistochemical analysis in bone marrow biopsy specimens: improved detection with use of beta-catenin.
Krishnan C; Twist CJ; Fu T; Arber DA
Am J Clin Pathol; 2009 Jan; 131(1):49-57. PubMed ID: 19095565
[TBL] [Abstract][Full Text] [Related]
16. [Value of immunological analysis for the detection of residual neuroblasts in the bone marrow].
Combaret V; Favrot MC; Bailly C; Philip I; Zucker JM; Philip T
Bull Cancer; 1988; 75(1):79-82. PubMed ID: 3282577
[TBL] [Abstract][Full Text] [Related]
17. Delayed surgery and bone marrow transplantation for widespread neuroblastoma.
Moss TJ; Fonkalsrud EW; Feig SA; Lenarsky C; Selch M; Wells J; Seeger RC
Ann Surg; 1987 Oct; 206(4):514-20. PubMed ID: 3310932
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma.
Moss TJ; Reynolds CP; Sather HN; Romansky SG; Hammond GD; Seeger RC
N Engl J Med; 1991 Jan; 324(4):219-26. PubMed ID: 1985243
[TBL] [Abstract][Full Text] [Related]
19. The role of bone marrow evaluation in the staging of patients with otherwise localized, low-risk neuroblastoma.
Russell HV; Golding LA; Suell MN; Nuchtern JG; Strother DR
Pediatr Blood Cancer; 2005 Dec; 45(7):916-9. PubMed ID: 16078212
[TBL] [Abstract][Full Text] [Related]
20. Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies.
Cheung NK; Von Hoff DD; Strandjord SE; Coccia PF
J Clin Oncol; 1986 Mar; 4(3):363-9. PubMed ID: 3081691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
